Stock Taper
SCREENER COMPARE ANY 2 STOCKS
KRYS
KRYSTAL BIOTECH, INC.
NASDAQ
$351.46
▼ DOWN 1.68% (-6.00)

KEY STATISTICS

Market Cap$10.36 B
52w High$382.54
52w Low$136.73
Dividend Yield—
Frequency—
P/E44.04
Volume143.50K
Shares Out.29.48M

COMPANY

LEADERSHIP

Krish S. Krishnan
CHIEF EXECUTIVE
Krish S. Krishnan

COMPENSATION 2026

Salary$846,167
Stock Awards$4,104,825
Incentive Plan Pay$0
All Other Comp.$134,000
Total$10,442,485

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 20, 2017
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
295

PRICE TARGET

Target High$474.00
Target Low$300.00
Target Median$380.50
Target Consensus$383.75

UPCOMING EARNINGS

DateNov 2, 2026
DayMonday
Rev. Est.$129.65M
NOV
2
MON

PRICE

$351.46 ▼ DOWN 1.68% (−$6.00)
$351$354$3579:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM351.46

About Krystal Biotech, Inc.

https://www.krystalbio.com ↗

Krystal Biotech, Inc. is a Pittsburgh-based biotech developing gene therapies for rare diseases and skin conditions, with products in various clinical and preclinical stages.

INDUSTRY

Biotechnology

A PRODUCT KRYSTAL BIOTECH, INC. IS KNOWN FOR

VYJUVEK (beremagene geperpavec-svdt)
VYJUVEK (beremagene geperpavec-svdt)

VYJUVEK is the first FDA-approved, topical, redosable gene therapy for DEB wounds, delivering the COL7A1 gene to promote healing and address the disorder's genetic cause.

COMPETITORS

COMPETITOR
ABEO COMPARE
INMB COMPARE

Revenue by Geography

MapREGIONQ1-2026Q2-2026
UNITED STATES$87.49M $91.63M ▲
Europe$20.68M $19.28M ▼
JAPAN$8.19M $8.31M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
248
LISTED HERE
26
RANKED BY POSITION SIZE
XMC.TO
0.26% · 917.4K
VTS.AX
0.01% · 892.4K
XBI
1.02% · 339.4K
SCHA
0.19% · 124.7K
DFAS
0.18% · 81.4K
PSC
0.57% · 44.3K
JSMD
0.96% · 29.0K
XRSU.L
0.29% · 23.7K
QMOM
1.88% · 22.9K
CSMD
1.59% · 21.7K
USVM
0.38% · 18.8K
FTXH
0.56% · 16.8K
FSMD
0.22% · 15.5K
RFG
1.40% · 13.7K
JHMM
0.07% · 12.8K
RSSL
0.29% · 12.5K
LABU
0.69% · 12.3K
GSC
1.17% · 9.3K
JMEE
0.10% · 8.7K
FSML
1.23% · 5.2K
BBP
1.38% · 4.6K
VIRS
1.96% · 4.4K
FFTY
1.97% · 4.2K
EZM
0.15% · 4.1K
BKMC
0.21% · 3.9K
RTWO.L
0.58% · 3.7K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
82.69%
HOLDERS
516
TOP 12 OF 516 · RANKED BY POSITION SIZE
Fmr LLC
4.4M sh · $1.64B
Blackrock, Inc.
4.2M sh · $1.55B
Blackrock Inc.
3.9M sh · $724.98M
Avoro Capital Advisors LLC
2.9M sh · $1.07B
Vanguard Group Inc
2.8M sh · $492.91M
State Street Corp
1.4M sh · $246.43M
Soleus Capital Management, L.P.
1.2M sh · $297.87M
Capital World Investors
824.7K sh · $213.04M
Vestor Capital, LLC
700.9K sh · $78.19M
Geode Capital Management, LLC
699.0K sh · $259.84M
Frazier Life Sciences Management, L.P.
688.5K sh · $121.53M
Price T Rowe Associates Inc /Md/
687.4K sh · $255.49M

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity4
Price To Earnings1
Price To Book1
Overall Score4

TRADES BY CONGRESS

HOUSE TRADES
Chris Jacobs
Chris Jacobs
Purchase
2022-12-12
 Christopher L. Jacobs
Christopher L. Jacobs
Purchase
2022-12-12

INSIDER TRADES

★
DIRECTOR
ROSSI DINO A
Sale · 40 shares
2026-08-14
★
DIRECTOR
ROSSI DINO A
Sale · 4.9K shares
2026-08-14
★
DIRECTOR
ROSSI DINO A
Sale · 3.1K shares
2026-08-14
★
DIRECTOR
ROSSI DINO A
Sale · 7.4K shares
2026-08-14

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 8
OUTPERFORM 1
9 GRADES IN THE LAST 12 MONTHS
Citigroup BUY B of A Securities BUY TD Cowen BUY HC Wainwright & Co. BUY Evercore ISI Group OUTPERFORM Guggenheim BUY Chardan Capital BUY Jefferies BUY

SECTORS PEERS

PEERPRICE
ARWR$84.91COMPARE
PTGX$144.33COMPARE
PCVX$59.84COMPARE
TGTX$53.93COMPARE
ALKS$47.41COMPARE
TFX$139.67COMPARE
PTCT$70.09COMPARE
CRSP$57.72COMPARE